3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
22
OTHER
16
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Recurrent Uterine Corpus Carcinoma
1
Recurrence
1
Neoplasm Metastasis
1
Genetic Diseases, Inborn
1
Breast Neoplasm Female
1
Interventions
Radiotherapy
9
Radiosurgery
6
Oxaliplatin
5
Cisplatin
5
Paclitaxel
4
Capecitabine
4
Leucovorin
3
Irinotecan
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
strontium chloride
2
regorafenib
2
pembrolizumab
2
enzalutamide
2
Zoledronic Acid
2
Temozolomide
2
Radiofrequency Ablation
2
Mitomycin
2
Methods
2
Ifosfamide
2
Gemcitabine
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Bleomycin
2
Bevacizumab
2
Analgesia
2
Albumin-Bound Paclitaxel
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Neoplasm Metastasis
×
Fulvestrant
×
Clear all
NCT02536742
2024-02-26
PYTHIA
ETOP IBCSG Partners Foundation
Phase 2
Completed
124 enrolled
10 charts